Results 31 to 40 of about 484,319 (306)

2019 Novel Coronavirus (COVID-19) Pandemic: Built Environment Considerations To Reduce Transmission. [PDF]

open access: yes, 2020
With the rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that results in coronavirus disease 2019 (COVID-19), corporate entities, federal, state, county, and city governments, universities, school districts, places of worship,
Coil, David A   +5 more
core   +2 more sources

Molecular immune pathogenesis and diagnosis of COVID-19

open access: yesJournal of Pharmaceutical Analysis, 2020
Coronavirus disease 2019 (COVID-19) is a kind of viral pneumonia which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The emergence of SARS-CoV-2 has been marked as the third introduction of a highly pathogenic coronavirus ...
Xiaowei Li   +4 more
doaj   +1 more source

Fatal spontaneous pneumomediastinum complicating SARS-COV2 pneumonia in a pregnant women

open access: yesJournal of Obstetric Anaesthesia and Critical Care, 2023
Pneumomediastinum was reported as a complication of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) pneumonia in the general population. Data concerning the association of this complication with pregnancy are rare.
Youssef Motiaa   +3 more
doaj   +1 more source

Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China. [PDF]

open access: yes, 2020
An in-depth annotation of the newly discovered coronavirus (2019-nCoV) genome has revealed differences between 2019-nCoV and severe acute respiratory syndrome (SARS) or SARS-like coronaviruses.
Cheng, Genhong   +15 more
core  

Systematic Comparison of Two Animal-to-Human Transmitted Human Coronaviruses: SARS-CoV-2 and SARS-CoV

open access: yesViruses, 2020
After the outbreak of the severe acute respiratory syndrome (SARS) in the world in 2003, human coronaviruses (HCoVs) have been reported as pathogens that cause severe symptoms in respiratory tract infections.
Jiabao Xu   +7 more
doaj   +1 more source

Review on development of potential inhibitors of SARS-CoV-2 main protease (MPro)

open access: yesFuture Journal of Pharmaceutical Sciences, 2022
Background The etiological agent for the coronavirus illness outbreak in 2019–2020 is a novel coronavirus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (COVID-19), whereas coronavirus disease pandemic of 2019 (COVID-19) has ...
Soumya Gulab Katre   +6 more
doaj   +1 more source

Case Report: A Severe Paediatric Presentation of COVID-19 in APDS2 Immunodeficiency

open access: yesFrontiers in Immunology, 2022
Critical respiratory manifestations of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) are rare in children, and little is known about how immunocompromised children respond to the infection.
Nuria Sanchez Clemente   +7 more
doaj   +1 more source

Genetic lesions within the 3a gene of SARS-CoV [PDF]

open access: yes, 2005
A series of frameshift mutations within the 3a gene has been observed in culture-derived severe acute respiratory syndrome coronavirus (SARS-CoV).
Barkham, Timothy   +7 more
core   +3 more sources

The SARS-coronavirus-host interactome [PDF]

open access: yes, 2011
Coronaviruses (CoVs) are important human and animal pathogens that induce fatal respiratory, gastrointestinal and neurological disease. The outbreak of the severe acute respiratory syndrome (SARS) in 2002/2003 has demonstrated human vulnerability to ...
Brunn, Albrecht von   +27 more
core   +1 more source

Two cases of spontaneous pneumomediastinum with pneumothorax in patients with COVID-19 associated pneumonia

open access: yesRespiratory Medicine Case Reports, 2020
Coronavirus 2019 (COVID-19) is an infectious viral illness caused by severe acute respiratory syndrome virus coronavirus 2 (SARS-CoV-2). This disease mainly affects the lungs manifesting as acute lung injury, pneumonia, and acute respiratory distress ...
Monique Oye   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy